ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
6,114.63
-0.01%
Dow Jones
44,546.08
-0.37%
US Dollar vs MXN
20.3062
0.00%
Brent Oil
74.39
0.00%
Bitcoin
97,222.67
-0.38%
Pepperstone
Advertisement
Registration Strip Icon for default Regístrate gratis para obtener cotizaciones en tiempo real, gráficos interactivos, flujo de opciones en vivo y más.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Reino Unido
  5. LSE
  6. Indivior Plc (INDV)

  7. Indivior Plc (INDV) Noticias

INDV

Indivior (INDV)

Indivior Plc
Fecha:
Ordernar por:
 Showing the most relevant articles for your search:LSE:INDV
FechaHoraFuenteTítuloSímboloCompañía
12/02/202503:18Alliance NewsAlliance NewsIN BRIEF: Indivior faces FDA delay on Sublocade label changeLSE:INDVIndivior Plc
12/02/202501:00RNS Regulatory NewsIndivior PLC Delayed FDA Approval of SUBLOCADE Label ChangesLSE:INDVIndivior Plc
12/02/202501:00PR Newswire (US)Indivior Statement RE: Delayed FDA Approval of SUBLOCADE® Label ChangesLSE:INDVIndivior Plc
04/02/202509:12RNS Regulatory NewsIndivior PLC Notice of ResultsLSE:INDVIndivior Plc
04/02/202504:41Alliance NewsAlliance NewsIN BRIEF: Indivior completes USD100 million share buybackLSE:INDVIndivior Plc
04/02/202501:00RNS Regulatory NewsIndivior PLC Transaction in Own SharesLSE:INDVIndivior Plc
04/02/202501:00RNS Regulatory NewsIndivior PLC Completion of Share Repurchase ProgramLSE:INDVIndivior Plc
03/02/202503:26RNS Regulatory NewsIndivior PLC Total Voting RightsLSE:INDVIndivior Plc
03/02/202501:00RNS Regulatory NewsIndivior PLC Appointment of Independent Non-Executive DirectorLSE:INDVIndivior Plc
28/01/202509:30RNS Regulatory NewsIndivior PLC Dr. David Wheadon appointed Chair of the BoardLSE:INDVIndivior Plc
28/01/202503:43RNS Regulatory NewsIndivior PLC Holding(s) in CompanyLSE:INDVIndivior Plc
16/01/202510:00RNS Regulatory NewsIndivior PLC Replacement Transaction in Own SharesLSE:INDVIndivior Plc
09/01/202507:00RNS Regulatory NewsIndivior PLC Indivior Provides Historical Financials in US GAAPLSE:INDVIndivior Plc
23/12/202404:32RNS Regulatory NewsIndivior PLC Director/PDMR ShareholdingLSE:INDVIndivior Plc
17/12/202401:00RNS Regulatory NewsIndivior PLC Indivior Announces Changes to Board of DirectorsLSE:INDVIndivior Plc
22/11/202401:00RNS Regulatory NewsIndivior PLC Indivior to Participate in Upcoming Investor EventLSE:INDVIndivior Plc
19/11/202411:52PR Newswire (US)Rapid Initiation with Once-monthly SUBLOCADE® Superior to Standard Initiation for Treating Opioid Use Disorder, Including in Fentanyl-Positive Patients, According to Data Presented at CSAM 2024LSE:INDVIndivior Plc
15/11/202401:00RNS Regulatory NewsIndivior PLC Director DeclarationLSE:INDVIndivior Plc
08/11/202410:50RNS Regulatory NewsIndivior PLC Block listing Interim ReviewLSE:INDVIndivior Plc
08/11/202403:55Alliance NewsAlliance NewsIndivior to talk with Oaktree after accusations of "value destruction"LSE:INDVIndivior Plc
08/11/202401:00RNS Regulatory NewsIndivior PLC Indivior Responds to Letter from OaktreeLSE:INDVIndivior Plc
07/11/202413:24PR Newswire (US)Indivior Responds to Publication of a Letter by Oaktree Capital Management to the Board of IndiviorLSE:INDVIndivior Plc
05/11/202405:19Alliance NewsAlliance NewsIndivior completes refinancing of secured term loanLSE:INDVIndivior Plc
05/11/202401:00RNS Regulatory NewsIndivior PLC Indivior Completes Refinance of Secured Term LoanLSE:INDVIndivior Plc
30/10/202411:30PR Newswire (US)Indivior Highlights Growing Body of Data on SUBLOCADE® (buprenorphine once-monthly extended-release injection) Helping Patients Achieve Long-Term Recovery from Opioid Use Disorder during Substance Abuse Prevention MonthLSE:INDVIndivior Plc
24/10/202401:00RNS Regulatory NewsIndivior PLC 3rd Quarter ResultsLSE:INDVIndivior Plc
24/10/202401:00PR Newswire (US)Indivior Announces Q3 2024 Financial ResultsLSE:INDVIndivior Plc
10/10/202413:30Alliance NewsAlliance NewsTOP NEWS: Shares in Indivior plunge 19% as profit warningLSE:INDVIndivior Plc
10/10/202406:00RNS Regulatory NewsIndivior PLC Preliminary Q3 Results & Updated FY 2024 GuidanceLSE:INDVIndivior Plc
10/10/202406:00PR Newswire (US)Indivior Provides Preliminary Q3 2024 Results; Updates FY 2024 Guidance; Group Continues to Expect SUBLOCADE Peak Net Revenue of >$1.5 BillionLSE:INDVIndivior Plc
 Showing the most relevant articles for your search:LSE:INDV

Su Consulta Reciente

NASDAQ
MGTX
MeiraGTx
NASDAQ
CUBA
Herzfeld Caribbean Basin
LSE
PBEE
Pensionbee
BIT
ADB
AEROPORTO GUGLIELMO MARC...
USOTC
REPYF
Repsol YPF (QX)
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

México
Empresa
Negocios
Popular
Obtener la aplicación
App Store
Google Play

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2025 ADVFN PLC - Todos los derechos reservados

Quitar anuncios

Suscríbete a una experiencia sin publicidad

Sin anuncios

Pruébalo ahora

Mantenga los anuncios